Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 831

1.

Lithium, anticonvulsants and suicidal behavior in bipolar disorder.

Yerevanian BI, Koek RJ, Mintz J.

J Affect Disord. 2003 Feb;73(3):223-8.

PMID:
12547290
2.

Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.

Yerevanian BI, Koek RJ, Mintz J.

J Affect Disord. 2007 Nov;103(1-3):5-11. Epub 2007 Jul 12.

PMID:
17628692
3.

Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.

Yerevanian BI, Koek RJ, Mintz J.

J Affect Disord. 2007 Nov;103(1-3):23-8. Epub 2007 Jun 29.

PMID:
17604119
4.

Heterogeneity of the risk of suicidal behavior in bipolar-spectrum disorders.

Cavazzoni P, Grof P, Duffy A, Grof E, Müller-Oerlinghausen B, Berghöfer A, Ahrens B, Zvolsky P, Robertson C, Davis A, Hajek T, Alda M.

Bipolar Disord. 2007 Jun;9(4):377-85.

PMID:
17547584
5.

Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.

Tondo L, Baldessarini RJ.

Epidemiol Psichiatr Soc. 2009 Jul-Sep;18(3):179-83. Review.

PMID:
20034193
6.
7.

Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants.

Yerevanian BI, Koek RJ, Mintz J, Akiskal HS.

J Affect Disord. 2007 Nov;103(1-3):13-21. Epub 2007 Jul 6.

PMID:
17617467
8.

Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide.

Søndergård L, Lopez AG, Andersen PK, Kessing LV.

Bipolar Disord. 2008 Feb;10(1):87-94. doi: 10.1111/j.1399-5618.2008.00464.x.

PMID:
18199245
9.

Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.

Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME.

J Clin Psychiatry. 2008 Jun;69(6):916-22.

PMID:
18399724
10.

Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.

Goldberg JF, Brooks JO 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, Miklowitz DJ, Ketter TA, Sachs GS, Thase ME.

J Clin Psychiatry. 2009 Feb;70(2):155-62. Epub 2009 Feb 10.

PMID:
19210946
11.

Newer prophylactic agents for bipolar disorder and their influence on suicidality.

Born C, Dittmann S, Post RM, Grunze H.

Arch Suicide Res. 2005;9(3):301-6.

PMID:
16020172
12.

Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium.

Baldessarini RJ, Tondo L, Hennen J.

Ann N Y Acad Sci. 2001 Apr;932:24-38; discussion 39-43. Review.

PMID:
11411189
13.

Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.

Collins JC, McFarland BH.

J Affect Disord. 2008 Apr;107(1-3):23-8. Epub 2007 Aug 16.

PMID:
17707087
14.

Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts.

Bocchetta A, Ardau R, Burrai C, Chillotti C, Quesada G, Del Zompo M.

J Clin Psychopharmacol. 1998 Oct;18(5):384-9.

PMID:
9790156
15.

Suicide attempts amongst elderly bipolar patients.

Aizenberg D, Olmer A, Barak Y.

J Affect Disord. 2006 Mar;91(1):91-4. Epub 2006 Jan 24.

PMID:
16434107
16.

[Bipolar depression and suicidal behavior].

Guillaume S, Courtet P, Samalin L.

Encephale. 2011 Dec;37 Suppl 3:S169-72. doi: 10.1016/S0013-7006(11)70047-1. Review. French.

PMID:
22212869
17.

Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.

Baldessarini RJ, Tondo L, Hennen J.

J Clin Psychiatry. 1999;60 Suppl 2:77-84; discussion 111-6. Review.

19.
20.

Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.

Gonzalez-Pinto A, Mosquera F, Alonso M, López P, Ramírez F, Vieta E, Baldessarini RJ.

Bipolar Disord. 2006 Oct;8(5 Pt 2):618-24.

PMID:
17042834

Supplemental Content

Support Center